DNA X Inc
SONM
14 hedge funds and large institutions have $691K invested in DNA X Inc in 2023 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 0 increasing their positions, 3 reducing their positions, and 3 closing their positions.
143% more capital invested
Capital invested by funds: $284K → $691K (+$406K)
33% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 3
8% more funds holding
Funds holding: 13 → 14 (+1)
0% more ownership
Funds ownership: 0.01% → 0.01% (+0%)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SA
Sicart Associates
New York
|
+$104K |
| 2 |
Jane Street
New York
|
+$9.3K |
| 3 |
BBA
Baader Bank Aktiengesellschaft
Unterschleissheim,
Germany
|
+$5.36K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$282 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$57.1K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$19.9K |
| 3 |
Renaissance Technologies
New York
|
-$19K |
| 4 |
VF
Virtu Financial
New York
|
-$5.36K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$564 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Bank of New York Mellon
New York
| $220K | – | – | – |
|
|
SA
2
Sicart Associates
New York
| $202K | +$104K | +1,111 | New |
|
|
3
Geode Capital Management
Boston,
Massachusetts
| $74.8K | -$564 | -6 | -1% |
|
|
4
Millennium Management
New York
| $46K | -$57.1K | -608 | -71% |
|
5
Vanguard Group
Malvern,
Pennsylvania
| $41.2K | – | – | – |
|
6
State Street
Boston,
Massachusetts
| $23.6K | – | – | – |
|
|
VF
7
Virtu Financial
New York
| $22K | -$5.36K | -57 | -32% |
|
|
8
Jane Street
New York
| $18K | +$9.3K | +99 | New |
|
9
Citigroup
New York
| $17.8K | – | – | – |
|
10
Northern Trust
Chicago,
Illinois
| $17.3K | – | – | – |
|
|
BBA
11
Baader Bank Aktiengesellschaft
Unterschleissheim,
Germany
| $8.09K | +$5.36K | +57 | New |
|
12
Wells Fargo
San Francisco,
California
| $137 | – | – | – |
|
|
EL
13
EMFO LLC
Weston,
Florida
| $101 | – | – | – |
|
|
14
UBS Group
Zurich,
Switzerland
| – | -$19.9K | -257 | Closed |
|
|
15
Renaissance Technologies
New York
| – | -$19K | -244 | Closed |
|
16
Fidelity Investments
Boston,
Massachusetts
| – | -$40 | -1 | Closed |
|
|
TRCT
17
Tower Research Capital (TRC)
New York
| – | +$282 | +3 | New |
|
SONM Hedge Fund Activity: Q1 2023 in Review
14 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in DNA X Inc (SONM) for Q1 2023, worth a combined $691K — up 143% from $284K a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new SONM positions and 3 closed out — a net gain of 1 holder — while 0 added to existing stakes and 3 trimmed.
The largest buyer was Sicart Associates, opening a new position worth an estimated $104K. The largest seller was Millennium Management, cutting an estimated $57.1K.
- 14 institutional investors held DNA X Inc (SONM) as of Q1 2023, up from 13 in Q4 2022.
- Funds reported $691K of DNA X Inc stock for Q1 2023, up 143% quarter-over-quarter.
- 4 funds opened new DNA X Inc positions in Q1 2023 and 3 closed out, a net change of +1 holder.
- The largest DNA X Inc buyer in Q1 2023 was Sicart Associates, an estimated $104K added.
- The largest DNA X Inc seller in Q1 2023 was Millennium Management, an estimated $57.1K sold.
Based on aggregated 13F filings for Q1 2023.